Dr. Brian Nahed is a neurosurgeon who specializes in Brain Tumors (Glioblastoma, Gliomas, Meningiomas, Metastatic Brain Tumors) and Spinal Disorders. He is an Associate Professor in the Department of Neurosurgery, MGH Brain Tumor Center and Harvard Medical School. Visit my web page.
Patient appointments: 617-724-5805. (Most appointments are within 24 hours.)
- Centers & Specialties
- Neuro-Oncology (Brain)
- Clinical Interests
- Brain tumors
- Metastatic Cancer of the brain (from melanoma, lung, etc)
- Intrinsic Brain Tumors (Gliomas, Glioblastomas, others)
- Awake and Language Mapping Craniotomy
- Recurrent Brain Tumors (post-treatment)
- Other cancers of the central nervous system
- Neurosurgical radiation oncology
- Spinal Tumor (Primary and Metastatic)
- Cervical and lumbar disc degeneration
- Degenerative spinal conditions
- Medical Education
- MSC, Harvard T. H. Chan School of Public Health
- MD, Yale University School of Medicine
- Residency, Massachusetts General Hospital
- Fellowship, New England Baptist Hospital
- Board Certifications
- Neurological Surgery
- Boston: Massachusetts General Hospital
- Existing Patients
- Patient Gateway
- Insurances Accepted
- Aetna Health Inc.
- AllWays Health (NHP) - ACD
- AllWays Health (NHP) - PBO
- Beech Street
- Blue Cross Blue Shield - Blue Care 65
- Blue Cross Blue Shield - Indemnity
- Blue Cross Blue Shield - Managed Care
- Blue Cross Blue Shield - Partners Plus
- BMC HealthNet Mass Health MCO/ACO
- Cigna (PAL #'s)
- Commonwealth Care Alliance
- Fallon Community HealthCare
- Great-West Healthcare (formally One Health Plan)
- Harvard Pilgrim Health Plan - ACD
- Harvard Pilgrim Health Plan - PBO
- Health Care Value Management (HCVM)
- Humana/Choice Care PPO
- Medicare - ACD
- OSW - Maine
- OSW - New Hampshire
- OSW - Rhode Island
- OSW - Vermont
- Private Health Care Systems (PHCS)
- Railroad Medicare
- Railroad Medicare - ACD
- Senior Whole Health
- Tufts Health Plan
- United Healthcare (non-HMO) - ACD
- United Healthcare (non-HMO) - PBO
- Well Sense Pediatrics
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
- Patient Age Group
- Provider Gender
Dr. Brian Nahed is a neurosurgeon specializing in brain tumors (glioblastoma, gliomas (low grade and high grade), metastatic brain tumors, and meningiomas) as well as Spinal Disorders. Dr. Nahed specializes in brain tumors of the eloquent cortex (language and motor areas of the brain) which require awake surgery, language and motor mapping, and subcortical stimulation.
Born in New York, Dr. Nahed attended UCLA where he majored in Neuroscience, graduating Phi Beta Kappa and with the department's Highest Honors. He attended the Yale School of Medicine where he was awarded the Doris Duke Clinical Research Fellowship and graduated with honors. Dr. Nahed completed his internship and neurosurgery residency at the Massachusetts General Hospital; where Dr. Nahed also completed a postdoctoral fellowship with Drs. Daniel Haber and Shyamala Maheswaran in the MGH Cancer Center.
Dr. Brian Nahed was recruited to the MGH Department of Neurosurgery and Brain Tumor Center in 2011. As an Associate Professor at Harvard Medical School, Dr. Brian Nahed's research focuses on developing the first blood based test to diagnose and monitor brain tumors. In collaboration with Drs. Haber, Maheswaran, and Stott, Dr. Nahed published the first evidence of circulating tumor cells in the blood of patients with glioma. Dr. Nahed hopes to provide patients and their clinicians with the first blood test for brain tumors.
Dr. Brian Nahed serves as the Associate Director of the MGH Neurosurgery Residency Program. He serves on the Executive Committee of the Congress of Neurological Surgeons and the CNS/AANS section on Tumors. He is an active member of the American Association of Neurological Surgeons and Council State Neurological Societies. Dr. Nahed is focused on education and socioeconomic issues in neurosurgery. He also serves as a neurotrauma consultant for the National Football League (NFL).
- Research Summary
Circulating Brain Tumor Cells and Blood Based Biomarkers for Brain Tumors
Dr. Brian Nahed's research recently identified the first evidence of tumor cells in the blood of patients with brain tumors - a landmark finding which changes our understanding of brain tumors and the blood. Dr. Brian Nahed and his colleagues developed the first device which they used to identify, capture, and analyze circulating tumor cells in the blood of patients with brain cancer. Through a collaboration between bioengineers, molecular biologists and clinicians, a circulating tumor cell capture device was developed to capture and detect tumor cells from patients with cancer. Under the mentorship of Drs. Daniel Haber, Shyamala Maheswaran, and Mehmet Toner, they aim to harness this technology to genetically characterize tumor cells without needing an invasive biopsy, and determine responsiveness to targeted cancer drugs. It also offers the opportunity to study cancer stem cells or metastasic precursors, thought to be at the origin of cancer spread via the bloodstream, to define their molecular vulnerabilities and help design new therapies to prevent cancer metastasis. Dr. Nahed has joined Dr. Shannon Stott to develop the first clinical tool to identify and monitor brain tumor patients using a blood test - expanding on their individual work on circulating tumor cells and exosomes.
Dr. Nahed's research was recently published in Cancer Discovery and he is active enrolling patients in his translational clinical research study. More information about his research lab can found at the the Nahed Brain Tumor Research Lab.
Dr. Brian Nahed has authored 112 publications in peer-reviewed journals and several book chapters and blogs.
Please refer to pubmed for a complete list of the publications.
Dr. Brian Nahed's research aims to develop the first blood test to diagnose brain tumors. Together with Dr. Shannon Stott, their research lab is focused on developing a liquid biopsy for patients with brain tumors . More information about the research can be found at the Brian Nahed Brain Tumor Research Lab Website or at www.briannahed.com.
In this new study, Shannon Stott, PhD and Brian Nahed, MD, MSc of the Mass General Cancer Center describe a new technique that uses microfluidics and engineered nanosurfaces to capture EVs released from glioblastoma multiforme, the most common and aggressive form of brain cancer.
Brian Nahed, MD, talks about the need to develop techniques to detect and monitor disease progression.
The Awards and Honors newsletter features recent awards and honors recognizing our talented and dedicated MGH staff and employees.
Drs. Shannon Stott and Brian Nahed are researching how microfluidic technologies can be applied to neurosurgery.
Liquid biopsies have the potential to revolutionize brain tumor diagnoses by providing better patient safety and supplying more details than traditional biopsies.
Brian V. Nahed, MD, Nader Pouratian, MD, PhD, and Martina Stippler, MD, Elected to Executive Committee of the Congress of Neurological Surgeons
Brian V. Nahed, MD, MSc, Nader Pouratian, MD, PhD, and Martina Stippler, MD were elected members-at-large of the Congress of Neurological Surgeons (CNS) Executive Committee for a two-year term, effective September 27, 2016. Their nominations were confirmed at the CNS Annual Business Meeting in San Diego, California.
A Massachusetts General Hospital Neurosurgeon Works to Develop the First Blood-Based Test for Patients with Brain Tumors.
55 Fruit Street
Boston, MA 02114